Baca berita tanpa iklan. Gabung

Indonesia Eyes Local Covid-19 Vaccine Mass Production by Mid-2021

July 3, 2020, 07.06 PM

The figure accounts for 176 million Indonesians who would each need two shots.

“Of course, the cost is expensive. It requires plenty of effort from all sides including researchers, academicians, and investors,” Ali said.

Ali added that it will take some time for people to receive the vaccine as it cannot be done all at once.

Read also: Daily Number of Coronavirus Cases Hits Nearly 1,400 in Indonesia

“We would need at least a year to vaccinate everyone.” 

Indonesia’s Covid-19 vaccine is being developed by state-owned enterprise PT Kalbe Farma, Tbk, and South Korea’s Genexine Inc.

Chief of the National Covid-19 Task Force Wiku Adisasmito had previously shared that the first clinical trials of the Covid-19 vaccine began in South Korea in June 2020.

The second phase of clinical trials is scheduled for August 2020 in Indonesia. 

(Writer: Ihsanuddin | Editor: Kristian Erdianto, Fabian Januarius Kuwado) 


Simak breaking news dan berita pilihan kami langsung di ponselmu. Pilih saluran andalanmu akses berita WhatsApp Channel : Pastikan kamu sudah install aplikasi WhatsApp ya.


Comment wisely and responsibly. Comments are entirely the responsibility of the commentator as regulated in the ITE Law
Thank You! We have received your report. We will remove comments that conflict with the Community Guidelines and the ITE Law.

More Headlines

April 14, 2023, 12.38 PM

Indonesia Detects New Covid Arcturus Variant

Baca berita tanpa iklan. Gabung
Baca berita tanpa iklan. Gabung


Baca berita tanpa iklan. Gabung
Baca berita tanpa iklan. Gabung
Close Ads